Globus Medical Launches MONUMENT Anterior Spondylolisthesis Reduction System
May 29 2014 - 4:30PM
Business Wire
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
implant manufacturer, today announced the launch of MONUMENT™, a
unique anterior lumbar interbody fusion device with a built-in
mechanical feature designed to aid in spondylolisthesis reduction.
The self-locking and threaded translational feature can be engaged
to reduce the implant up to 8mm in situ and the screws are designed
for optimal cortical purchase.
MONUMENT Anterior Spondylolisthesis
Reduction System. Credit: Globus Medical
“MONUMENT™, with its threaded translational reduction feature,
is designed to be more efficient for the surgeon by incorporating
mechanized implant reduction with an integrated plate-spacer.
Alternative procedures require additional steps in treating this
challenging condition. Our new system includes all the benefits
typical of an anterior lumbar interbody spacer with a large
stabilizing surface area and large graft window to optimize
fusion,” commented Andrew Iott, Senior Vice President of Product
Development.
“The implant’s translational reduction feature performs
exceptionally well. MONUMENT™ offers the benefits of an integrated
ALIF system and simple, intuitive instruments combined with in-situ
implant reduction, making it an attractive surgical solution for
patients with spondylolisthesis,” commented Christopher Tomaras,
MD, Neurosurgeon at Peachtree Neurosurgery in Atlanta, Georgia.
The MONUMENT™ Spacer is available in different sizes, heights
and sagittal angles to accommodate the lumbar and sacral spine,
including L5-S1. The device is intended for use with supplemental
fixation.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal implant
company based in Audubon, PA. The company was founded in 2003 by an
experienced team of professionals with a shared vision to create
products that enable surgeons to promote healing in patients with
musculoskeletal disorders. Additional information can be accessed
at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than
statements of historical fact are forward-looking statements and
may be identified by their use of words such as “believe,” “may,”
“might,” “could,” “will,” “aim,” “estimate,” “continue,”
“anticipate,” “intend,” “expect,” “plan” and other similar terms.
These forward-looking statements are based on our current
assumptions, expectations and estimates of future events and
trends. Forward-looking statements are only predictions and are
subject to many risks, uncertainties and other factors that may
affect our businesses and operations and could cause actual results
to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, factors affecting
our quarterly results, our ability to manage our growth, our
ability to sustain our profitability, demand for our products, our
ability to compete successfully (including without limitation our
ability to convince surgeons to use our products and our ability to
attract and retain sales and other personnel), our ability to
rapidly develop and introduce new products, our ability to develop
and execute on successful business strategies, our ability to
comply with changing laws and regulations that are applicable to
our businesses, our ability to safeguard our intellectual property,
our success in defending legal proceedings brought against us,
trends in the medical device industry, general economic conditions,
and other risks. For a discussion of these and other risks,
uncertainties and other factors that could affect our results, you
should refer to the disclosure contained in our most recent annual
report on Form 10-K filed with the Securities and Exchange
Commission, including the sections labeled “Risk Factors” and
“Cautionary Note Concerning Forward-Looking Statements,” and in our
Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at www.sec.gov.
Moreover, we operate in an evolving environment. New risk factors
and uncertainties emerge from time to time and it is not possible
for us to predict all risk factors and uncertainties, nor can we
assess the impact of all factors on its business or the extent to
which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any
forward-looking statements. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on any
forward-looking statements. Forward-looking statements contained in
this press release speak only as of the date of this press release.
We undertake no obligation to update any forward-looking statements
as a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20140529006376/en/
Globus Medical, Inc.Ed Joyce,
610-930-1800investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Sep 2023 to Sep 2024